Tsuboi M - Search Results

1

Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer.

Wu YL, Tsuboi M, He J, John T, Grohe C, Majem M, Goldman JW, Laktionov K, Kim SW, Kato T, Vu HV, Lu S, Lee KY, Akewanlop C, Yu CJ, de Marinis F, Bonanno L, Domine M, Shepherd FA, Zeng L, Hodge R, Atasoy A, Rukazenkov Y, Herbst RS; ADAURA Investigators. Wu YL, et al. Among authors: tsuboi m. N Engl J Med. 2020 Oct 29;383(18):1711-1723. doi: 10.1056/NEJMoa2027071. Epub 2020 Sep 19. N Engl J Med. 2020. PMID: 32955177 Clinical Trial.

2

[Current status of adjuvant chemotherapy for the resected non-small cell lung cancer].

Tsuboi M, Kato H. Tsuboi M, et al. Nihon Rinsho. 2002 May;60 Suppl 5:329-34. Nihon Rinsho. 2002. PMID: 12101682 Review. Japanese. No abstract available.

3

A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung.

Kato H, Ichinose Y, Ohta M, Hata E, Tsubota N, Tada H, Watanabe Y, Wada H, Tsuboi M, Hamajima N, Ohta M; Japan Lung Cancer Research Group on Postsurgical Adjuvant Chemotherapy. Kato H, et al. Among authors: tsuboi m. N Engl J Med. 2004 Apr 22;350(17):1713-21. doi: 10.1056/NEJMoa032792. N Engl J Med. 2004. PMID: 15102997 Free article. Clinical Trial.

4

[Guidelines for the treatment of lung cancer with lymph node involvement].

Ikeda N, Tsuboi M, Ohira T, Hirano T, Kato H. Ikeda N, et al. Among authors: tsuboi m. Nihon Geka Gakkai Zasshi. 2004 Jul;105(7):404-7. Nihon Geka Gakkai Zasshi. 2004. PMID: 15303439 Review. Japanese.

5

Identification of postoperative adjuvant chemotherapy responders in non-small cell lung cancer by novel biomarker.

Hirano T, Kato H, Maeda M, Gong Y, Shou Y, Nakamura M, Maeda J, Yashima K, Kato Y, Akimoto S, Ohira T, Tsuboi M, Ikeda N. Hirano T, et al. Among authors: tsuboi m. Int J Cancer. 2005 Nov 10;117(3):460-8. doi: 10.1002/ijc.21172. Int J Cancer. 2005. PMID: 15900595 Free article.

6

[The application of extended resection for non-small cell lung cancer].

Tsuboi M, Harubumi K. Tsuboi M, et al. Nihon Geka Gakkai Zasshi. 2005 Jun;106(6):367-74. Nihon Geka Gakkai Zasshi. 2005. PMID: 15977578 Review. Japanese.

7

Postoperative adjuvant therapy for completely resected early-stage non-small cell lung cancer.

Kato H, Tsuboi M, Kato Y, Ikeda N, Okunaka T, Hamada C. Kato H, et al. Among authors: tsuboi m. Int J Clin Oncol. 2005 Jun;10(3):157-64. doi: 10.1007/s10147-005-0493-x. Int J Clin Oncol. 2005. PMID: 15990962 Review.

8

Gefitinib in the adjuvant setting: safety results from a phase III study in patients with completely resected non-small cell lung cancer.

Tsuboi M, Kato H, Nagai K, Tsuchiya R, Wada H, Tada H, Ichinose Y, Fukuoka M, Jiang H. Tsuboi M, et al. Anticancer Drugs. 2005 Nov;16(10):1123-8. doi: 10.1097/00001813-200511000-00012. Anticancer Drugs. 2005. PMID: 16222155 Clinical Trial.

9

Early-stage lung cancer: diagnosis and treatment.

Ohira T, Suga Y, Nagatsuka Y, Usuda J, Tsuboi M, Hirano T, Ikeda N, Kato H. Ohira T, et al. Among authors: tsuboi m. Int J Clin Oncol. 2006 Feb;11(1):9-12. doi: 10.1007/s10147-005-0553-2. Int J Clin Oncol. 2006. PMID: 16508723 Review. No abstract available.

10

Interstitial lung disease in patients with non-small-cell lung cancer treated with epidermal growth factor receptor inhibitors.

Tsuboi M, Le Chevalier T. Tsuboi M, et al. Med Oncol. 2006;23(2):161-70. doi: 10.1385/MO:23:2:161. Med Oncol. 2006. PMID: 16720916

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

979 results

Search Page